All times are listed in CEST (Central European Summer Time)

Browsing Over 461 Presentations

Sort By
EONS - Supportive care issues in breast cancer (ID 11)

Cachexia syndrome in breast cancer patients (ID 275)

Lecture Time
14:45 - 14:45
Speakers
Authors
Session Name
EONS - Supportive care issues in breast cancer (ID 11)
Room
Cologne Hall
Date
Wed, 04.05.2022
Time
14:45 - 16:15
José Baselga: Cancer’s fiercest opponent (ID 49)

Panel discussion (ID 477)

Lecture Time
11:05 - 11:20
Authors
Session Name
José Baselga: Cancer’s fiercest opponent (ID 49)
Room
Berlin Hall
Date
Tue, 03.05.2022
Time
10:00 - 11:20
Keynote lecture: Optimising adjuvant treatment in HR+/HER2 negative early breast cancer (ID 29)

Introduction by the Chairs (ID 310)

Lecture Time
15:40 - 15:40
Speakers
Authors
Session Name
Keynote lecture: Optimising adjuvant treatment in HR+/HER2 negative early breast cancer (ID 29)
Room
Berlin Hall
Date
Tue, 03.05.2022
Time
15:40 - 16:10
EONS - Taking care of disadvantaged people with breast cancer: What’s the evidence? (ID 18)

Immigrants and refugees (ID 343)

Lecture Time
08:45 - 08:45
Speakers
Authors
Session Name
EONS - Taking care of disadvantaged people with breast cancer: What’s the evidence? (ID 18)
Room
Cologne Hall
Date
Wed, 04.05.2022
Time
08:45 - 10:15
Mini Oral session 1 (ID 6)

Invited Discussant 59MO, 60MO, 91MO and 92MO (ID 5)

Lecture Time
16:43 - 16:53
Speakers
Authors
Session Name
Mini Oral session 1 (ID 6)
Room
Frankfurt Hall
Date
Tue, 03.05.2022
Time
16:15 - 17:30
Keynote lecture: How shall our knowledge of cancer evolution transform breast oncology? (ID 20)

Introduction by the Chairs (ID 378)

Lecture Time
14:10 - 14:10
Speakers
Authors
Session Name
Keynote lecture: How shall our knowledge of cancer evolution transform breast oncology? (ID 20)
Room
Berlin Hall
Date
Wed, 04.05.2022
Time
14:10 - 14:40
Gilead - Triple-Negative Breast Cancer: See Beyond the Negatives (ID 35)

Live Q&A (ID 411)

Lecture Time
11:30 - 11:30
Session Name
Gilead - Triple-Negative Breast Cancer: See Beyond the Negatives (ID 35)
Room
Munich Hall
Date
Tue, 03.05.2022
Time
11:30 - 12:30
Risk based prevention and screening in breast cancer (ID 31)

MyPeBS study (ID 443)

Lecture Time
13:45 - 13:45
Speakers
Authors
Session Name
Risk based prevention and screening in breast cancer (ID 31)
Room
Frankfurt Hall
Date
Tue, 03.05.2022
Time
13:45 - 15:15
AstraZeneca - Controversies in Breast Cancer (ID 48)

Treatment beyond CDK4/6i - what comes next? (ID 471)

Lecture Time
12:00 - 12:15
Speakers
Authors
Session Name
AstraZeneca - Controversies in Breast Cancer (ID 48)
Room
Cologne Hall
Date
Tue, 03.05.2022
Time
11:30 - 12:30
Proffered Paper session 1 (ID 12)

Invited Discussant LBA3 and 162O (ID 305)

Lecture Time
14:15 - 14:25
Speakers
Authors
Session Name
Proffered Paper session 1 (ID 12)
Room
Munich Hall
Date
Tue, 03.05.2022
Time
13:45 - 15:15
Genetic testing and implications in early breast cancer (eBC) patients (ID 19)

Best additional systemic treatment options for eBC in the era of PARP inhibitors (ID 338)

Lecture Time
08:45 - 08:45
Speakers
Authors
Session Name
Genetic testing and implications in early breast cancer (eBC) patients (ID 19)
Room
Frankfurt Hall
Date
Wed, 04.05.2022
Time
08:45 - 10:15
Seagen - Treatment sequencing in HER2-positive metastatic breast cancer: from guidelines to clinical practice (ID 30)

Summary and session close (ID 373)

Lecture Time
13:20 - 13:20
Speakers
Authors
Session Name
Seagen - Treatment sequencing in HER2-positive metastatic breast cancer: from guidelines to clinical practice (ID 30)
Room
Munich Hall
Date
Wed, 04.05.2022
Time
13:00 - 14:00